Centric Health Corporation (TSE:CHH) price target upped to $0.50, issued a ratings update earlier today by National Bank Financial
- Updated: September 23, 2016
Just yesterday Centric Health Corporation (TSE:CHH) traded 1.30% higher at $0.39. Centric Health Corporation’s 50-day moving average is $0.36 and its 200-day moving average is $0.27. The last closing price is up 44.83% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 375,100 shares of Centric Health Corporation traded, up from an avg. volume of 234,606
Reporting as potential upside of 0.28%, National Bank Financial upped the price target of Centric Health Corporation (TSE:CHH) to $0.50
With a total market value of $0, Centric Health Corporation has price-earnings ratio of 1.43 with a one year low of $0.19 and a one year high of $0.44 .
Brief Synopsis About Centric Health Corporation (TSE:CHH)
Centric Health Corporation is a Canada-based provider of healthcare services. The Company's segments include Specialty Pharmacy, and Surgical and Medical Centres. The Specialty Pharmacy segment includes dispensing, compliance packaging and auxiliary products and services for retirement homes and long-term care residents. The Specialty Pharmacy segment also offers dispensing services in Ontario and British Columbia for employees insured by corporate health plans. The Surgical & Medical Centres segment includes a range of services, including primary care, executive medical, urgent care and diagnostic services, including computerized tomography (CT) and magnetic resonance imaging (MRI) scan capabilities. The Surgical & Medical Centres segment also offers surgical specialties, including plastic, reconstructive, cosmetic, orthopedic, gynecology, urology, neurosurgery, bariatric, endoscopic and otolaryngology. It operates across approximately 500 locations across the country.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.